CHA2DS2-VASc score the appropriate tool to evaluate thrombotic or bleeding complications? What next?doi:10.1016/j.hjc.2020.11.005Dimitris TousoulisHellenic Journal of Cardiology
the AliveCor Heart Monitor to Screen for Atrial Fibrillation), a randomized trial of screening for atrial fibrillation (AF) with a smartphone-based single-lead electrocardiographic capture system in 1001 patients ≥65 years of age with a CHA2DS2-VASc score of ≥ 2 and without a history of AF...
a希望我们能永远过着幸福快乐的日子 正在翻译,请等待...[translate] acompare to the old one BOM 与老一BOM比较[translate] aRapid Pioneer 迅速先驱[translate] aThe higher CHA2DS2-VASc score may increase the presence and burden of concomitant intracranial atherosclerosis in ischemic stroke patients with...
a- Spots or uneven color on the surface due to defects in material or due to poor cleaning. -斑點或參差不齊的顏色在表面由於瑕疵在物質或由於惡劣的清潔。[translate] acompare to the old one BOM 与老一BOM比较[translate] aThe higher CHA2DS2-VASc score may increase the presence and burden of...
the authors proposed the use of a scoring system of differentiated indications for use of anticoagulation in which the currently established CHADS2-score is supplemented by the CHA2DS2-VASc score, this should make possible, especially for low-risk patients with atrial fibrillation, a better different...
AHRAI AHRB AHRC AHRCB AHRCC AHRCO AHRD AHRDA AHRDC AHRDCC AHRDS AHRE AHREOC AHRF AHRG AHRH AHRI AHRIC AHRIM AHRIMS AHRIO AHRIS AHRL AHRLA AHRM AHRMA AHRMIO AHRMM AHRMNY AHRN AHRNE AHRO AHROC AHROS AHRP AHRPO AHRQ ▼
What is the Usefulness of Renal Dysfunction in Predicting Thromboembolism in Addition to CHADS2 and CHA2DS2-VASc scores?TzeFan Chao, MD
The CHA2DS2-VASc score is not validated in patients with severe CKD and has a low predictive value in dialysis patients. As NOACs are partly eliminated by the kidneys the dosage has to be adapted in CKD. Recent studies indicate an acceptable safety profile for NOACs in CKD. However, ...
the authors proposed the use of a scoring system of differentiated indications for use of anticoagulation in which the currently established CHADS2-score is supplemented by the CHA2DS2-VASc score, this should make possible, especially for low-risk patients with atrial fibrillation, a better different...
In many patients with paroxysmal or permanent nonvalvular atrial fibrillation and a CHA2DS2-VASc score of 2 or more, warfarin or other newer oral anti-coagulant therapies are contra-indicated, or are not prescribed, for a variety of reasons. These patients are therefore at risk of serious ...